Full Press Release Details
SAN FRANCISCO , Dec. 27, 2018 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR ) President and Chief Executive Officer, Howard Robin , is scheduled to present at the upcoming 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2019 at 9:00 a.m. Pacific Time .
The presentation will be accessible via a Webcast through a link posted on the Investors, Events Calendar section of the Nektar website: https://ir.nektar.com/events-and-presentations/events . In addition, the company will webcast the Q&A breakout session immediately following its presentation at 9:30 a.m. Pacific Time . This Webcast will be available for replay until February 18, 2019 .
About Nektar Therapeutics Nektar Therapeutics is a research-based development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco, California , with additional operations in Huntsville, Alabama and Hyderabad, India . Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com .
For Investors: Jennifer Ruddock of Nektar Therapeutics 415-482-5585
Jodi Sievers of Nektar Therapeutics 415-482-5593
For Media: Dan Budwick of 1AB 973-271-6085 [email protected]
SOURCE Nektar Therapeutics